← Leaderboards
Olivia M Martinez
Stanford University
$20,491,021
Attributed
$22,456,150
Total exposure
11
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$22,456,150 · 11
By mechanism
R01$8,276,176 · 4
U01$6,664,639 · 2
T32$6,039,463 · 1
R56$803,453 · 2
R21$672,419 · 2
Top collaborators
- Sheri M. Krams4 shared
- Sean Curtis Bendall1 shared
Others in their field
Top investigators on “Transplant Recipients”
- Leland H Hartwell · Fred Hutchinson Cancer Research Center$84,240,435
- Peter Scott Heeger · Case Western Reserve University$83,635,934
- Joren C Madsen · Massachusetts General Hospital$58,876,734
- Mary M Horowitz · Medical College Of Wisconsin$55,693,586
- Peter G Stock · University Of California San Francisco$39,243,787
- Leslie S Kean · Emory University$39,217,487
Research focus
Transplant RecipientsLymphoproliferative DisordersB-Cell LymphomasB-LymphocytesMolecularSolidApoptosisInfected B CellProductionInterleukin-10Human Herpesvirus 4TransplantationMalignant NeoplasmsLymphomaT-LymphocyteOrganCellsEpstein-Barr Virus InfectionsPathway InteractionsAutocrineGrowthSignal TransductionOrgan TransplantationViral
Grant awards (49)
Epstein Barr Virus Driven Mechanisms of Post Transplant Lymphoproliferative Disease$1,872,252
U01 · FY2025 · CA · contact PI
Molecular and Cellular Immunobiology$432,408
T32 · FY2025 · AI · contact PI
Epstein Barr Virus Driven Mechanisms of Post Transplant Lymphoproliferative Disease$596,508
U01 · FY2024 · CA · contact PI
Molecular and Cellular Immunobiology$515,677
T32 · FY2024 · AI · contact PI
Epstein Barr Virus Driven Mechanisms of Post Transplant Lymphoproliferative Disease$627,903
U01 · FY2023 · CA · contact PI
Molecular and Cellular Immunobiology$504,249
T32 · FY2023 · AI · contact PI
Molecular and Cellular Immunobiology$438,642
T32 · FY2022 · AI · contact PI
The Impact of Epstein Barr Virus Infection on the Immune Response in Pediatric Transplant Recipients$338,000
U01 · FY2021 · AI · contact PI
Molecular and Cellular Immunobiology$92,427
T32 · FY2021 · AI · contact PI
The Impact of Epstein Barr Virus Infection on the Immune Response in Pediatric Transplant Recipients$1,075,681
U01 · FY2020 · AI · contact PI
The Impact of Epstein Barr Virus Infection on the Immune Response in Pediatric Transplant Recipients$605,532
U01 · FY2020 · AI · contact PI
New Therapeutics for Post-Transplant Lymphoproliferative Disorder$398,138
R01 · FY2020 · AI · contact PI
Molecular and Cellular Immunobiology$255,529
T32 · FY2020 · AI · contact PI
Molecular and Cellular Immunobiology$1,320,701
T32 · FY2019 · AI · contact PI
The Impact of Epstein Barr Virus Infection on the Immune Response in Pediatric Transplant Recipients$913,096
U01 · FY2019 · AI · contact PI
New Therapeutics for Post-Transplant Lymphoproliferative Disorder$398,138
R01 · FY2019 · AI · contact PI
Molecular and Cellular Immunobiology$1,212,982
T32 · FY2018 · AI · contact PI
The Impact of Epstein Barr Virus Infection on the Immune Response in Pediatric Transplant Recipients$635,667
U01 · FY2018 · AI · contact PI
New Therapeutics for Post-Transplant Lymphoproliferative Disorder$398,138
R01 · FY2018 · AI · contact PI
Molecular and Cellular Immunobiology$1,266,848
T32 · FY2017 · AI · contact PI
New Therapeutics for Post-Transplant Lymphoproliferative Disorder$398,138
R01 · FY2017 · AI · contact PI
Targeting B Cell MicroRNA in Post-Transplant EBV-Associated B Cell Lymphoma$197,731
R21 · FY2017 · AI · contact PI
New Therapeutics for Post-Transplant Lymphoproliferative Disorder$398,138
R01 · FY2016 · AI · contact PI
Targeting B Cell MicroRNA in Post-Transplant EBV-Associated B Cell Lymphoma$237,417
R21 · FY2016 · AI · contact PI
New Therapeutics for Post-Transplant Lymphoproliferative Disorder$402,265
R56 · FY2014 · AI · contact PI
Cellular Mechanisms of PTLD in Transplant Recipients$409,571
R01 · FY2012 · AI · contact PI
Cellular Mechanisms of PTLD in Transplant Recipients$408,411
R01 · FY2011 · AI · contact PI
Cellular Mechanisms of PTLD in Transplant Recipients$411,227
R01 · FY2010 · AI · contact PI
Tolerance Induction and Viral Infection in Liver Transplantation$401,188
R56 · FY2010 · AI
Cellular Mechanisms of PTLD in Transplant Recipients$353,157
R01 · FY2009 · AI · contact PI
Cellular Mechanisms of PTLD in Transplant Recipients$47,463
R01 · FY2009 · AI · contact PI
Cellular Mechanisms of PTLD in Transplant Recipients$354,265
R01 · FY2008 · AI · contact PI
Pathways of Death and Survival in EBV B Cell Lymphomas$248,803
R01 · FY2008 · CA · contact PI
Cellular Mechanisms of PTLD in Transplant Resipients$341,065
R01 · FY2007 · AI · contact PI
Pathways of Death and Survival in EBV B Cell Lymphomas$248,803
R01 · FY2007 · CA · contact PI
Cellular Mechanisms of PTLD in Transplant Resipients$350,565
R01 · FY2006 · AI · contact PI
Pathways of Death and Survival in EBV B Cell Lymphomas$256,234
R01 · FY2006 · CA · contact PI
Cellular Mechanisms of PTLD in Transplant Resipients$358,325
R01 · FY2005 · AI
Pathways of Death and Survival in EBV B Cell Lymphomas$262,400
R01 · FY2005 · CA
Cellular Mechanisms of PTLD in Transplant Resipients$360,259
R01 · FY2004 · AI
Pathways of Death and Survival in EBV B Cell Lymphomas$262,400
R01 · FY2004 · CA
CYTOKINES AND LIVER TRANSPLANTATION$287,461
R01 · FY2003 · DK
Cellular Mechanisms of PTLD in Transplant Resipients$79,925
R01 · FY2003 · AI
CYTOKINES AND LIVER TRANSPLANTATION$279,104
R01 · FY2002 · DK
Cellular Mechanisms of PTLD in Transplant Recipients$237,271
R21 · FY2002 · AI
CYTOKINES AND LIVER TRANSPLANTATION$270,992
R01 · FY2001 · DK
CELLULAR MECHANISMS OF PTLD IN TRANSPLANT RECIPIENTS$197,189
R01 · FY2001 · AI
CYTOKINES AND LIVER TRANSPLANTATION$263,119
R01 · FY2000 · DK
CELLULAR MECHANISMS OF PTLD IN TRANSPLANT RECIPIENTS$234,748
R01 · FY2000 · AI